LOW PRICED SCRIP

Dalal Street Investment Journal|June 08 - 21, 2020

LOW PRICED SCRIP
MARKSANS PHARMA WHERE HEALTH IS WEALTH HERE IS WHY Good financial improvements in last three years. Diversified revenue sources Good growth prospects

Marksans Pharma manufactures and markets analgesics, expectorants as well as the anti-diabetic, cardiovascular, central nervous system, gastrointestinal and oncologic drugs in addition to antibiotic and anti-allergic products. The company also engages in research, offering contract research manufacturing services to global pharmaceutical companies. It is headquartered in Mumbai with subsidiaries across the globe. Its footprint extends across the United Kingdom, the United States, and Australia, coupled with proprietary marketing networks in these countries.

articleRead

You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber

GoldLogo

Get unlimited access to thousands of curated premium stories and 5,000+ magazines

READ THE ENTIRE ISSUE

June 08 - 21, 2020